Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision

2021 ◽  
Author(s):  
Samer Naffouje ◽  
Arvind Sabesan ◽  
Benjamin D. Powers ◽  
Sophie Dessureault ◽  
Julian Sanchez ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Adjuvant Chemotherapy ◽  
Total Mesorectal Excision ◽  
Cancer Patients ◽  
Neoadjuvant Chemoradiation ◽  
Stage Ii ◽  
Mesorectal Excision ◽  
Patient Risk

Neoadjuvant radiotherapy and anastomosis dehiscence after total mesorectal excision for stage II and III rectal cancer

2007 ◽  
Vol 12 (2) ◽  
pp. 87-93 ◽  
Author(s):  
Bartłomiej Szynglarewicz ◽  
Rafał Matkowski ◽  
Adam Maciejczyk ◽  
Piotr Kasprzak ◽  
Daniel Sydor ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Stage Ii ◽  
Mesorectal Excision ◽  
Neoadjuvant Radiotherapy

Prognosis of rectal cancer patients after total mesorectal excision

2009 ◽  
Vol 28 (9) ◽  
pp. 903-907
Author(s):  
Zhi-Zhong Pan ◽  
Pei-Rong Ding ◽  
De-Sen Wan ◽  
Li-Ren Li ◽  
Xiao-Jun Wu ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Cancer Patients ◽  
Mesorectal Excision

Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients

2009 ◽  
Vol 99 (1) ◽  
pp. 58-64 ◽  
Author(s):  
Young-Wan Kim ◽  
Nam-Kyu Kim ◽  
Byung-Soh Min ◽  
Hyuk Huh ◽  
Jin-Soo Kim ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Total Mesorectal Excision ◽  
Cancer Patients ◽  
Mesorectal Excision ◽  
Anastomotic Recurrence ◽  
Factors Associated
Sign in / Sign up

Export Citation Format

Share Document